<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240313061278N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-04-03</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of electromyographic biofeedback on the electromyographic activity of the shoulder girdle muscles in primary impingement syndrome</public_title>
      <acronym></acronym>
      <scientific_title>To compare the shoulder girdle exercises with and without electromyographic biofeedback on the electromyography activity of the shoulder girdle muscles in individuals with primary impingement syndrome: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/76112</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The sample size in each group is 15 people (45 people in total). Permuted block randomization is used for randomization. For this, we use blocks of six in the following order. In each block, a means the intervention group (EMG biofeedback with exercise and routine physiotherapy), b (exercise therapy along with routine physiotherapy) and c (routine physiotherapy alone) means the control groups. First, a number is assigned to each of the blocks (aabbcc cabbac abcabc bacbac cbaabc bbaacc ccaabb aaccbb ccbbaa) randomly from 1 to 9, then people are placed in the blocks from block one and from the left. and based on the letter (a, b, and c) that is chosen for each person, the person enters the intervention or control groups. The participants, the therapist and the evaluator will be unaware of the grouping. To implement the generated random sequence, the method of hiding the box or coded cans is used. In this method, the cans will be numbered based on a random sequence, and inside the boxes, the intended intervention will be provided to the therapist with a sheet on which random allocation is written, with the condition that the boxes are sealed and completely confidential. and the therapist will assign them to the intervention and control groups based on the order of arrival of the patients, Blinding description: A physiotherapist will be in charge of the treatment process and another physiotherapist will evaluate the desired variables. For this reason, the study will be a single-blind study from the evaluator.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary shoulder impingement syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Treatment in the intervention group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). At the beginning of the treatment sessions, 20 minutes of hot pack, 20 minutes of conventional transcutaneous electrical nerve stimulation (TENS) and 5 minutes of 1 MHz and 1.5 intensity ultrasound are performed. Then, before doing the exercises, the people of this group perform upper limb cycling exercises without resistance for 5 minutes, then, based on the standard shoulder exercise protocol, progressive resistance exercises of the external rotator muscles of the arm (infraspinatus and teres minor) including external rotation exercises of the arm in the neutral position, 45 degrees of abduction, 90 degrees of abduction and in the weight bearing position and progressive resistance exercises of the stabilizer muscles of the movement of the external rotation of the arm (middle and lower trapezius) including scapular retraction and T and Y exercises with EMG biofeedback and under external resistance by Theraband. The amount of resistance applied by Theraband (Theraband color) is increased and determined as a percentage of the maximal voluntary isometric contraction (MVIC) of each muscle according to the desired week from 50% to 80% of MVIC. This resistance is determined weekly. Also, the exercises are done in 10 repetition in each set, and the number of sets increases from 2 sets to 3 sets according to the desired week. Also, oscillation is added to the end of the exercises to apply more resistance along with the progress of the exercises. At the end, a cold pack is used for 10 minutes to prevention of pain and inflammation after the exercises. Range of motion exercises are repeated ten times a day and stretching exercises are performed five times a day. Intervention 2: Control group: The treatment in the first control group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). The treatment in this group will be the same as the intervention group, with the difference that this group will perform exercises without EMG biofeedback. exercise resistance is also determined by Theraband and based on the percentage of MVIC at the beginning of each week (Theraband color), then the people of this group perform the exercises with the determined Theraband and without EMG biofeedback. Intervention 3: Control group: The treatment in the second control group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). In this group, only routine physiotherapy including 20 minutes of hot pack, 20 minutes of conventional transcutaneous electrical nerve stimulation (TENS) and 5 minutes of 1 MHz and 1.5 intensity ultrasound is performed, and this group does not perform therapeutic exercise intervention. At the end of the study, the results will be evaluated and compared with other groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehran Borjipour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neuromuscular Rehabilitation Research Center, Quds Blvd.</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519698375</zip>
        <telephone>+98 23 3332 8502</telephone>
        <email>borjimehran78@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Cyrus Taghizadeh Delkhoush</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neuromuscular Rehabilitation Research Center, Quds Blvd.</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519698375</zip>
        <telephone>+98 23 3332 8502</telephone>
        <email>cyrustaghizadeh@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Onset of shoulder pain less than a year ago
Pain in the anterior or lateral part of the upper arm
Shoulder pain in the range of VAS less than 4 (1 to 3)
Positiveness of at least 3 of the following: painful arch during flexion or abduction movements - positive Neer test - positive Kennedy-Hawkins test - positive Jobe test - pain during resisted movement of external rotation or abduction
The involved side is the dominant side of the person
Persistent pain for at least one week in the past six months
Without limitation in shoulder range of motion
Age between 18 and 35 years
Normal BMI (18.5 to 24.9)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pain in both shoulders at the same time
Positive drop arm test for complete rotator cuff tear
Instability or hypermobility of the glenohumeral joint (sulcus sign)
History of heart disease
pregnancy
Person cannot work with electromyographic biofeedback
Other orthopedic diseases in the upper quadrant of the skeleton
Systemic diseases
Neurological diseases
Surgery, fracture, dislocation or subluxation in the upper quadrant of the skeleton
People who have taken corticosteroid drugs in the last six months
People who have taken any medicine in the previous two weeks
People who have received cervical or shoulder girdle rehabilitation in the last six months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Impingement syndrome of shoulder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Treatment in the intervention group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). At the beginning of the treatment sessions, 20 minutes of hot pack, 20 minutes of conventional transcutaneous electrical nerve stimulation (TENS) and 5 minutes of 1 MHz and 1.5 intensity ultrasound are performed. Then, before doing the exercises, the people of this group perform upper limb cycling exercises without resistance for 5 minutes, then, based on the standard shoulder exercise protocol, progressive resistance exercises of the external rotator muscles of the arm (infraspinatus and teres minor) including external rotation exercises of the arm in the neutral position, 45 degrees of abduction, 90 degrees of abduction and in the weight bearing position and progressive resistance exercises of the stabilizer muscles of the movement of the external rotation of the arm (middle and lower trapezius) including scapular retraction and T and Y exercises with EMG biofeedback and under external resistance by Theraband. The amount of resistance applied by Theraband (Theraband color) is increased and determined as a percentage of the maximal voluntary isometric contraction (MVIC) of each muscle according to the desired week from 50% to 80% of MVIC. This resistance is determined weekly. Also, the exercises are done in 10 repetition in each set, and the number of sets increases from 2 sets to 3 sets according to the desired week. Also, oscillation is added to the end of the exercises to apply more resistance along with the progress of the exercises. At the end, a cold pack is used for 10 minutes to prevention of pain and inflammation after the exercises. Range of motion exercises are repeated ten times a day and stretching exercises are performed five times a day.</i_keyword>
      <i_keyword>Control group: The treatment in the first control group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). The treatment in this group will be the same as the intervention group, with the difference that this group will perform exercises without EMG biofeedback. exercise resistance is also determined by Theraband and based on the percentage of MVIC at the beginning of each week (Theraband color), then the people of this group perform the exercises with the determined Theraband and without EMG biofeedback.</i_keyword>
      <i_keyword>Control group: The treatment in the second control group (15 people) includes 24 sessions (8 weeks, 3 days a week, every other day). In this group, only routine physiotherapy including 20 minutes of hot pack, 20 minutes of conventional transcutaneous electrical nerve stimulation (TENS) and 5 minutes of 1 MHz and 1.5 intensity ultrasound is performed, and this group does not perform therapeutic exercise intervention. At the end of the study, the results will be evaluated and compared with other groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Normalized muscle electrical activity. Timepoint: Before and After of the Intervention. Method of measurement: Surface EMG.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain. Timepoint: Before and After of the Intervention. Method of measurement: Visual analogue scale (VAS).</sec_outcome>
      <sec_outcome>Functional disability. Timepoint: Before and After of the Intervention. Method of measurement: The disabilities of the arm, shoulder and hand (DASH) questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-11</approval_date>
        <contact_name>Research Ethics Committees of Semnan University Of Medical Sciences and Health Services</contact_name>
        <contact_address>Basij Blvd, Semnan University of Medical Sciences Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
